Jazz Pharmaceuticals plc — Director's Dealing 2014

Nov 10, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-11-07

Reporting Person: McGill Iain (Head of EUSA Int'l & SVP)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-07	Ordinary Shares	M	4166	$46.83	Acquired	28990	Direct
2014-11-07	Ordinary Shares	M	1500	$59.13	Acquired	30490	Direct
2014-11-07	Ordinary Shares	S	5666	$172.0315	Disposed	24824	Direct
2014-11-07	Ordinary Shares	S	1400	$172.00	Disposed	23424	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-07	Nonstatutory Stock Option (right to buy)	$46.83	M	4166	Disposed	2022-08-08	Ordinary Shares (4166)	Direct
2014-11-07	Nonstatutory Stock Option (right to buy)	$59.13	M	1500	Disposed	2023-03-04	Ordinary Shares (1500)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172 to $172.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F2: Following the reported transaction, the remaining ordinary shares subject to this option vest in equal monthly installments from November 9, 2014 to August 9, 2016.

F3: Following the reported transaction, the remaining ordinary shares subject to this option vest in equal monthly installments from December 5, 2014 to March 5, 2017.